In Vitro Fertilization Market Synopsis

In Vitro Fertilization Market Size Was Valued at USD 759.40 Million in 2023 and is Projected to Reach USD 1718.69 Million by 2032, Growing at a CAGR of 9.5% From 2024-2032.

In Vitro Fertilization is a process of Fertilization in which eggs are removed from a woman’s ovary and combined with sperm outside the body in vitro conditions to form embryos. The embryos are grown in the laboratory for several days and then either placed in a woman’s uterus or cryopreserved for future use also called IVF.

• The IVF technique can be more beneficial in Overcoming infertility, for couples who have difficulty conceiving naturally due to factors like blocked fallopian tubes, low sperm count, or any other ovulation disorders.
• It is also applicable in Genetic screening to screen embryos for genetic disorders, this helps in the selection of healthy embryos for transfer and reduces the risk of passing on genetic conditions
• It also allows individuals to preserve their fertility by cryopreservation technique for freezing embryos, eggs, or sperm for future use, which is particularly helpful for individuals who are undergoing treatments like chemotherapy which may affect their fertility.
• It also enables same-gender couples and single individuals to have biological children. It is used in gestational surrogacy, which allows individuals to carry a pregnancy and have a biological child for those who have no child.
• It has also contributed to advancements in reproductive research, like studying early embryonic development and improving assisted reproductive technologies.

Top Active Players Involved are:

“TFP Fertility, Vitrolife AB, Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA (EMD Serono), Ferring Pharmaceuticals, Esco Micro Pte Ltd, Boston IVF, IVFtech ApS, Rocket Medical plc, IVI Fertility, THE COOPER COMPANIES, INC, COOK GROUP, VITROLIFE, Servy Massey Fertility Institute, Houston Fertility Center, Conceptions Reproductive Associates of Colorado, New Hope Fertility Center, Sher Institute for Reproductive Medicine (Sirm), Cardone Reproductive Medicine and Infertility, Fertility Center of San Antoni, Reproductive Medicine Associate, Fertility And Gynecology Center Monterey Bay Ivf, Nikon Corporation, Cooper Companies Inc. and Other Active Players.”

In Vitro Fertilization Market Trend Analysis

Delayed Onset of Pregnancy

• As women, nowadays are facing a delay in pregnancy for many reasons such as career advancement, education, or personal choices. Women's fertility declines with age, particularly after the age of 35, due to a decrease in the quality and quantity of eggs. IVF offers a suitable option for couples who are struggling with age-related infertility.
• Increased awareness and acceptance of advancements in reproductive technologies, hence more people are seeking IVF Technique. Some individuals are also choosing to preserve their fertility through egg or embryo freezing by cryopreservation technique when they are young or delayed in pregnancy.
• Social and cultural changes like shifts in family planning norms and, the desire to have children later in life, have contributed to the increased demand for IVF services. Hence, in this way, Delayed Pregnancies act as a driver in Invitro Fertilization.

Opportunity

Increase Launches of IVF Facilities and New Technologies

• Stem Cell treatment in which, Stem cells are undifferentiated cells that can develop into any type of cell in the body, where these stem cells may be able to repair damaged tissue in the ovaries and improve egg quality, leading to better outcomes for fertility treatment.
• Laser Assisted Hatching is a technique that involves making a small hole in the outer layer of the embryo to help it hatch and implant in the uterus, this technique has been shown to improve the success rate of IVF in specific patient groups.
• Cryopreservation is a technique that involves preserving fertility by freezing eggs, sperm, or embryos for future use. Mitochondrial Replacement Therapy, in which the defective mitochondria from the mother’s egg are replaced with a healthy one from the egg of the donor helps in preventing mitochondrial diseases.
• Preimplantation Genetic Screening helps to improve the chances of successful pregnancy and reduce the risk of miscarriage. In Vitro, Maturation Technique is useful for those individuals who have issues with the maturation of their eggs.
• Embryoscopy Treatment in which Time-lapse imaging allows doctors to monitor the development of embryos in real time and select the most viable ones for transfer. It is to improve the success rate of IVF and reduce the number of multiple pregnancies. The use of nanotechnology also has enabled suitable sperm cells to chosen that enables leading to the development of a healthy embryo. Hence, in this way, The new launches of IVF Facilities and Technological Advancements act as an opportunity.

In Vitro Fertilization Market Segment Analysis:

In Vitro Fertilization Market Segmented on the basis of Product Type, Type, Cycle, End-User, Segment5, And Segment6.

By Cycle, Fresh-Non-Donor Segment Is Expected to Dominate the Market During the Forecast Period

• Fresh non-donor cycles often have higher success rates when compared to other segments. As in the IVF process, Fresh eggs and sperm have a better chance of resulting in successful fertilization and implantation.
• They are considered the best choice for Personalized treatment, where the individual's eggs and sperm allow for a closer genetic match, potentially increasing the chances of successful fertilization and implantation.
• The availability of fresh eggs and sperm from the intended parents is relatively easier to manage compared to acquiring donor gametes. This cycle is more convenient and accessible.
• They are often more cost-effective when compared to other options, like using donor eggs or frozen embryos. In this way, fresh non-donor cycles are a preferred choice for many individuals, and couples who are looking for IVF Treatment.

By End-User, Fertility Clinics Segment Held the Largest Share In 2023

• Fertility clinics are dedicated to healthcare facilities that are equipped with specialized infrastructure, laboratories, and advanced reproductive technologies that offer fertility treatments, including IVF, making them a primary choice for individuals and couples who are looking for reproductive services.
• They are staffed with highly skilled fertility specialists, reproductive endocrinologists, embryologists, and other healthcare professionals who have extensive experience in diagnosing and managing fertility-related issues.
• They provide a wide range of services related to fertility evaluation, ovulation induction, diagnostic testing, egg retrieval, embryo transfer, and post-treatment monitoring.
• They often engage in research and clinical trials, where these advancements include techniques like intracytoplasmic sperm injection, preimplantation genetic testing, time-lapse embryo monitoring, and many other techniques.
• They also collaborate with reproductive endocrinology specialists, urologists, gynecologists, and other healthcare providers to treat the patients properly by taking care, of them without any issues. Hence, In this way, Fertility Clinics are dominant and play a major role in IVF.

• The global fertility services market was valued at 20 billion U.S. dollars in 2018, this value was 32 billion U.S. dollars in 2023, increased by 12 billion U.S. dollars. Women choosing to have children at a later age is said to be a large factor behind the growth of this market as more people will require fertility services.

In Vitro Fertilization Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast Period

• The Asia Pacific region has a huge population, and also fertility issues are prevalent in the region. Factors like changing lifestyles, delayed pregnancies, and increasing awareness of fertility treatments have contributed to a rise in demand for Invitro Fertilization services.
• It has embraced technological advancements in the field of IVF, including improved laboratory techniques, genetic testing, embryo selection methods, and many others, these advancements have led to an increase in the success rate in pregnancy of women.
• Rising disposable incomes have made IVF treatments more accessible to a larger population and also countries like China, Japan, and India have medical tourism, which is attracting patients from other countries due to the availability of high-quality, and Low-cost treatments compared to other countries.
• The government policies and initiatives to support assisted reproductive technologies in this region are also helping the people through funding in many ways. Hence, in this way, this region is dominated by IVF treatments.

In Vitro Fertilization Market Active Players

• Tfp Fertility (UK)
• Vitrolife Ab (Sweden)
• Irvine Scientific (USA)
• Thermo Fisher Scientific Inc. (USA)
• Merck Kgaa (Emd Serono) (Germany)
• Ferring Pharmaceuticals (Switzerland)
• Esco Micro Pte Ltd (Singapore)
• Boston Ivf (USA)
• Ivftech Aps (Denmark)
• Rocket Medical Plc (USA)
• Ivi Fertility (Spain)
• The Cooper Companies, Inc. (USA)
• Cook Group (USA)
• Vitrolife (Sweden)
• Servy Massey Fertility Institute (USA)
• Houston Fertility Center (USA)
• Conceptions Reproductive Associates of Colorado (USA)
• New Hope Fertility Center (USA)
• Sher Institute for Reproductive Medicine (Sirm) (USA)
• Cardone Reproductive Medicine and Infertility (USA)
• Fertility Center of San Antoni (USA)
• Reproductive Medicine Associate (USA)
• Fertility And Gynecology Center Monterey Bay Ivf (USA)
• Nikon Corporation (Japan)
• Cooper Companies Inc. (USA)And Other Active Players.

Key Industry Developments in the In Vitro Fertilization Market:

• In April 2024, Gameto a female-led biotechnology company with a mission to redefine women's healthcare, Announced New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solutions for Fertility Care, this process by which a therapy developed from induced pluripotent stem cells (iPSC) has the potential to enhance in vitro fertilization.
• In March 2024, Alife Health a leading fertility technology company specializing in the development of AI tools for in vitro fertilization announced a groundbreaking partnership with Boston IVF, a leading fertility clinic to pilot the country's first AI tool for IVF medication optimization which is designed to help IVF clinicians to retrieve the optimal number of eggs for each patient and reduce overall medication costs.